Clinical trial
A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From…
NCT00354653 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00354653 |
|---|---|
| Title | A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone |
| Official title | AN OPEN STUDY OF LAMIVUDINE TREATMENT IN ADULT HBeAg NEGATIVE (Presumed Pre-core Mutant) CHRONIC HEPATITIS B PATIENTS IN IRAN. |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | CHRONIC HEPATITIS B |
| Intervention type | Drug |
| Interventions | LAMIVUDINE |
| Enrollment | 100 |
| Start date | Feb 9, 2002 |
| Primary completion | Jan 23, 2007 |
| Completion | Jan 23, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | Mar 3, 2020 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: